barr 555 727
Pill imprint barr 555 727 has been identified as Estropipate 0.75 mg.
Estropipate is used in the treatment of oophorectomy; atrophic vaginitis; atrophic urethritis; primary ovarian failure; postmenopausal symptoms (and more), and belongs to the drug class estrogens. Not for use in pregnancy.
Estropipate 0.75 mg is not subject to the Controlled Substances Act.
See also related documents.
Estropipate Images
- Imprint:
-
barr
555 727 - Strength:
- 0.75 mg
- Color:
- Yellow
- Size:
- 9.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
crospovidone
lactose monohydrate
magnesium stearate
corn starch
D&C Yellow No. 10
FD&C Yellow No. 6
aluminum oxide
- Drug Class:
- Estrogens
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Barr Laboratories, Inc.
- National Drug Code (NDC):
- 00555-0727
| NDC Code | Manufacturer / Repackager |
|---|---|
| 66336-0977 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Estropipate resources
- Estropipate (Wolters Kluwer)
- estropipate (Cerner Multum)
- Estropipate (FDA)
- Estropipate (Piperazine Estrone Sulfate) (Wolters Kluwer)
Search Again
